Sulfanyltriazole/tetrazoles: A Promising Class of HIV-1 NNRTIs

E-ISSN： 1875-5607|9|8|1014-1023

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.9, Iss.8, 2009-07, pp. : 1014-1023

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel integrase inhibitor promising in triple-class resistant HIV-1

Inpharma, Vol. 1, Iss. 1560, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Structure-Activity Relationship Studies on Clinically Relevant HIV-1 NNRTIs

Current Medicinal Chemistry, Vol. 19, Iss. 31, 2012-11 ,pp. : 5364-5380

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in DAPYs and Related Analogues as HIV-1 NNRTIs

Current Medicinal Chemistry, Vol. 18, Iss. 3, 2011-01 ,pp. : 359-376

Bentham Science Publishers

Access to resources Recommend Favorite

Small-Molecule Antagonists of CCR5 and CXCR4: A Promising New Class of Anti-HIV-1 Drugs

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2041-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Progress of Bis(heteroaryl)piperazines (BHAPs) as Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) against Human Immunodeficiency Virus Type 1 (HIV-1)

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 1, 2010-01 ,pp. : 62-72

Bentham Science Publishers

Access to resources Recommend Favorite